Notice of Intent to Publish a Funding Opportunity Announcement for Intellectual and Developmental Disabilities Research Centers 2025 (P50 Clinical Trial Optional)
NICHD plans to fund IDD research centers via P50 grants, fostering collaborative basic, translational, and clinical studies to improve IDD diagnosis, treatment, and prevention.
Funder: National Institutes of Health
Due Dates: October 15, 2025 (estimated, forecast) | October 2, 2026 (application deadline)
Funding Amounts: Up to $800,000 per award per year; total program funding estimated at $18,000,000; expected duration 3 years.
Summary: Supports multidisciplinary research centers advancing the diagnosis, prevention, treatment, and amelioration of intellectual and developmental disabilities.
Key Information: Limited to current IDDRC P50 awardees from RFA-HD-20-016 or RFA-HD-21-009; not open to new applicants.
Description
This limited competition opportunity invites applications for the Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Centers (IDDRCs). The program supports multidisciplinary research centers that advance the diagnosis, prevention, treatment, and amelioration of intellectual and developmental disabilities (IDD). Centers are required to facilitate interdisciplinary and translational research through 3–4 core facilities, support at least two and no more than three specific research projects in priority IDD areas, and include robust outreach and engagement with the community, including individuals with lived experience of disabilities. Collaborative projects spanning translational science, biomarker assessment, outcome measures, tool validation, bioinformatics, and therapeutic development are encouraged.
